ramelteon has been researched along with Stroke in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| He, L; Li, M; Qi, X; Shao, X; Tang, Z; Wang, J; Wang, Z; Yu, X; Zhang, X | 1 |
| Kawada, K; Miyamura, M; Ohta, T; Tanaka, K; Tanaka, S | 1 |
| Miyake, K; Murao, K; Ohta, T; Takemoto, K | 1 |
1 trial(s) available for ramelteon and Stroke
| Article | Year |
|---|---|
Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium Risk in Acute Stroke Patients.
Topics: Aged; Aged, 80 and over; Azepines; Delirium; Drug Therapy, Combination; Female; GABA Agonists; Humans; Indenes; Male; Orexin Receptor Antagonists; Receptors, Melatonin; Retrospective Studies; Risk Factors; Sleep; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Stroke; Treatment Outcome; Triazoles | 2019 |
2 other study(ies) available for ramelteon and Stroke
| Article | Year |
|---|---|
Ramelteon improves blood-brain barrier of focal cerebral ischemia rats to prevent post-stroke depression via upregulating occludin.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Depression; Endothelial Cells; Infarction, Middle Cerebral Artery; Mice; Occludin; Rats; Reperfusion Injury; Stroke | 2023 |
Melatonin receptor agonists for treating delirium in elderly patients with acute stroke.
Topics: Aged; Aged, 80 and over; Delirium; Female; Humans; Indenes; Male; Middle Aged; Prognosis; Receptors, Melatonin; Stroke; Treatment Outcome | 2013 |